Mild Plasmodium falciparum malaria following an episode of severe malaria is associated with induction of the interferon pathway in Malawian children

Infection and Immunity

Volumn 80, Issue 3, 2012, Pages 1150-1155

  Krupka, Malkie ^a   Seydel, Karl ^b,c   Feintuch, Catherine M ^a   Yee, Kenny ^a   Kim, Ryung ^a   Lin, Chang Yun ^a   Calder, R Brent ^a   Petersen, Christine ^d   Taylor, Terrie ^b,c   Daily, Johanna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MALAWI   (Malawi)

^d IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE I; CATHEPSIN W; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 89B; INTERFERON; INTERFERON INDUCED PROTEIN TRANSCRIPT 1; INTERFERON INDUCED PROTEIN TRANSCRIPT 2; INTERFERON INDUCED PROTEIN TRANSCRIPT 3; MYXOVIRUS RESISTANCE 1; MYXOVIRUS RESISTANCE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OLIGOADENYLATE SYNTHETASE 1; OLIGOADENYLATE SYNTHETASE 3; PERFORIN; SMALL NUCLEOLAR RNA; SYNTHETASE; THYMIDINE KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SMEAR; BRAIN MALARIA; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CYTOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALAWI; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEVERE MALARIA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; INTERFERONS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; MALAWI; MALE; PLASMODIUM FALCIPARUM; SIGNAL TRANSDUCTION;

EID: 84863280753     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06008-11     Document Type: Article

References (42)

1. Andrade BB, Barral-Netto M. 2011. Biomarkers for susceptibility to infection and disease severity in human malaria. Mem. Inst. Oswaldo Cruz 106(Suppl 1):70-78.
2. Aponte JJ, et al. 2007. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 4:e242.
3. Aucan C, et al. 2003. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 4:275-282.
4. Baird JK. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11:105-111.
5. Berry MP, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977.
6. Birbeck GL, et al. 2010. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am. J. Trop. Med. Hyg. 82:231-234.
7. Boivin MJ, et al. 2010. Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria. Trop. Med. Int. Health 16:263-271.
8. Breman JG, Alilio MS, Mills A. 2004. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg. 71:1-15.
9. Carneiro I, et al. 2010. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 5:e8988.
10. Chelimo K, et al. 2011. Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1. PLoS One 6:e24852.
11. Durbin JE, et al. 2000. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164:4220-4228.
12. Flo TH, et al. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921.
13. Grau GE, et al. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-1591.
14. Griffiths MJ, et al. 2005. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 191:1599-1611.
15. Haque A, et al. 2011. Type I interferons suppress CD4 T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41:2688-2698.
16. Ji TH, Grossmann M, Ji I. 1998. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273:17299-17302.
17. Khor CC, et al. 2007. Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus. Genes Immun. 8:570-576.
18. Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. 2011. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 31:41-47.
19. Lindskog S. 1997. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther. 74:1-20.
20. Marsh K, et al. 1995. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332:1399-1404.
21. Mohammed AO, et al. 2003. Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria. Acta Tropica 87:279-285.
22. Morrell CN, et al. 2011. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 79:1750-1758.
23. Oakley MS, et al. 2011. Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect. Immun. 79:1244-1253.
24. Ockenhouse CF, Bernstein WB, Wang Z, Vahey MT. 2005. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191:2064-2074.
25. Ojo-Amaize EA, et al. 1981. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J. Immunol. 127:2296-2300.
26. Pankla R, et al. 2009. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10:R127.
27. Peters PJ, et al. 1991. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173:1099-1109.
28. Reich M, et al. 2006. GenePattern 2.0. Nat. Genet. 38:500-501.
29. Rhodes-Feuillette A, et al. 1985. The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures. J. Interferon Res. 5:159-168.
30. Sharma S, et al. 2011. Innate immune recognition of an AT-rich stemloop DNA motif in the Plasmodium falciparum genome. Immunity 35:194-207.
31. Stephens R, Langhorne J. 2010. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 6:e1001208.
32. Stevenson MM, Riley EM. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180.
33. Stoeckle C, et al. 2009. CathepsinWexpressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp. Hematol. 37:266-275.
34. Stryker GA, Nickell SP. 1995. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent. Exp. Parasitol. 81:564-573.
35. Subramanian A, et al. 2005. Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
36. Taylor TE, Borgstein A, Molyneux ME. 1993. Acid-base status in paediatric Plasmodium falciparum malaria. Q. J. Med. 86:99-109.
37. Taylor TE, et al. 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10:143-145.
38. Thach DC, et al. 2005. Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes. Genes Immun. 6:588-595.
39. Tsuji M, Zavala F. 2003. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol. 19:88-93.
40. Vaena de Avalos S, Blader IJ, Fisher M, Boothroyd JC, Burleigh BA. 2002. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:639-644.
41. Vigario AM, et al. 2007. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 178:6416-6425.
42. WHO. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2006/9241546948_eng.pdf.